Table 2.
Oncological outcomes of breast cancer patients who underwent surgery and additional treatments
| Follow-up period (months), mean±SD | 100.54±18.5 |
|
| |
| Disease-free survival, n (%) | 1026 (89.4) |
|
| |
| Locoregional recurrencea, n (%) | 64 (5.6) |
| Ipsilateral breast | 23 (2.0) |
| Ipsilateral axillary lymph node | 25 (2.2) |
| Ipsilateral supraclavicular lymph node | 24 (2.1) |
| Ipsilateral internal mammary lymph node | 8 (0.7) |
|
| |
| Distant metastasisa, n (%) | 85 (7.4) |
| Lung | 48 (4.2) |
| Bone | 38 (3.3) |
| Liver | 34 (3.0) |
| Brain | 14 (1.2) |
| Mediastinal lymph node | 9 (0.8) |
| Others | 6 (0.5) |
|
| |
| Death, n (%) | 52 (4.5) |
SD, standard deviation.
a
The organs could be duplicated.